Sera Prognostics Inc (SERA)
8.25
-0.13
(-1.55%)
USD |
NASDAQ |
May 17, 16:00
8.25
0.00 (0.00%)
After-Hours: 20:00
Sera Prognostics Free Cash Flow (Quarterly): 4.282M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.282M |
| December 31, 2023 | -6.781M |
| September 30, 2023 | -7.62M |
| June 30, 2023 | -7.995M |
| March 31, 2023 | -4.92M |
| December 31, 2022 | -7.431M |
| September 30, 2022 | -9.149M |
| June 30, 2022 | -9.257M |
| March 31, 2022 | -9.564M |
| Date | Value |
|---|---|
| December 31, 2021 | -9.901M |
| September 30, 2021 | -9.725M |
| June 30, 2021 | -6.323M |
| March 31, 2021 | -6.991M |
| December 31, 2020 | -4.229M |
| September 30, 2020 | -4.006M |
| June 30, 2020 | -4.159M |
| March 31, 2020 | -4.623M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.901M
Minimum
Dec 2021
4.282M
Maximum
Mar 2024
-6.376M
Average
-6.991M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| RadNet Inc | -40.32M |
| DermTech Inc | -12.54M |
| iSpecimen Inc | -2.357M |
| 23andMe Holding Co | -14.07M |
| Progyny Inc | 24.88M |